Quick Facts
  • Primary Location:
    Rutgers Cancer Institute of New Jersey
  • Expertise:
    Cytoreductive Surgery
    HIPEC
  • Speciality:
    Surgical Oncology
  • Gender:
    Male
  • Language:
    English
  • Med School:
    Georgetown University School of Medicine

Get to Know Dr. H. Richard Alexander

In addition to treating patients as the chief surgical officer at Rutgers Cancer Institute, Dr. H. Richard Alexander serves as a professor of surgery at Rutgers Robert Wood Johnson Medical School.

Alexander joined Rutgers in 2017 after serving as head of surgical oncology at the University of Maryland School of Medicine and Greenebaum Cancer Center.

In his clinical practice, Alexander offers innovative treatment options for rare cancers such as peritoneal mesothelioma. Over the past two decades, he helped pioneer advances in therapy that are now being used across the country.

Through his research, Alexander developed various treatment combinations that have better managed different abdominal cancers, often by targeting molecular mutations.

His multidisciplinary approach to mesothelioma treatment often combines intravenous chemotherapy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, which has proven highly effective.

He also treats appendiceal cancer, colorectal cancer and other abdominal tumors.

Contact Richard Alexander
Mesothelioma specialist speaking with a patient and his wife
Talk to a Doctor About Your Diagnosis
We can help you or a loved one get in contact with Dr. Alexander and find the treatment that’s best for you.

Specialties of Dr. H. Richard Alexander

  • Cytoreductive surgery
  • Hyperthermic intraperitoneal chemotherapy
  • Peritoneal mesothelioma
  • Gastrointestinal cancers
  • Neuroendicrine tumors

Dr. H. Richard Alexander’s Experience and Medical Education

  • Rutgers Cancer Institute of New Jersey
  • Greenebaum Comprehensive Cancer Center, University of Maryland
  • National Cancer Institute (Surgery branch)
  • Memorial Sloan Kettering Cancer Center (Fellowship)
  • Walter Reed National Military Medical Center (Residency)
  • Georgetown University School of Medicine (M.D.)

Awards and Certifications

  • American College of Surgeons (Fellow)
  • American Surgical Association (Fellow)
  • Society of Surgical Oncology (Fellow)
  • Royal College of Surgeons, Glasgow (Honorary member)
  • National Institutes of Health Award of Merit

Publications of Dr. H. Richard Alexander

  • Adhikary, G. et al. (2018, October 2). Transglutaminase is a mesothelioma cancer stem cell survival protein that is required for tumor formation. Oncotarget.
  • Alexander, H.R. et al. (2018, August 25). Current Management and Future Opportunities for Peritoneal Metastases: Peritoneal Mesothelioma. Annals of Surgical Oncology.
  • Alexander, H.R. & Burke, A. (2016, February 7). Diagnosis and management of patients with malignant peritoneal mesothelioma. Journal of Gastrointestinal Oncology.
  • Alexander, H.R. (2010, January). Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present and Future. Annals of Surgical Oncology.

Lab technician using a microscope in a lab
COVID-19 and Mesothelioma Presentation
United States one-hundred-dollar bills
Access More than $32 Billion in Trust Funds
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

  •  
  •  
  •  
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?